Curidium: Bringing the Right Drug to the Right Patient

/ / /

	ABOUT US
	PERSONALIZED MEDICINE & CNS
	PRODUCTS & TECHNOLOGY
	BUSINESS DEVELOPMENT
	INVESTORS
	MEDIA


	Financial Reports

	Constitutional Documents

	RNS Announcements

	Share Details

	Share Price

	Analyst Coverage

	Committees

	Company Overview

	Board of Directors

	Advisers

Curidium Medica plc is covered by:

JM Finn Capital Markets

Edison Research

Curidium Medica plc © 2006-2008 | Email: Tel.: +44 (0)20 7554 5100
This site was last updated on 13.10.08